Johnson & Johnson (JNJ) Stock: Surge as FDA Approval and European Cancer Treatme...
TLDR Johnson & Johnson gains momentum after FDA approves Imaavy for rare blood disorder. JNJ expands cancer care reach after Europ...
SpaceX (SPCX) Stock: Surges as $100 Billion Louisiana Starship Spaceport Plan Ex...
TLDR SpaceX plans a $100 billion Louisiana Starship spaceport to expand launch capacity. New Louisiana facility will support thous...
AstroNova, Inc. (ALOT) Stock: Approves $29 Per Share Acquisition Deal With Arcli...
TLDR AstroNova shares traded at $28.99 after merger approval with Arcline. Shareholders approved the $29 per share cash acquisitio...
Morningstar, Inc. (MORN) Stock: Targets AI Investment Research With New Gemini E...
TLDR: Morningstar shares fell 1.41% as Gemini Enterprise integration plans emerged. Morningstar and PitchBook will ground Gemini r...
Quantum Cyber N.V. (QUCY) Stock: Gains as Company Expands U.S. Defense Sales
TLDR Quantum Cyber stock rises as new sales leadership boosts U.S. defense expansion plans QUCY advances drone manufacturing strat...
Nvidia (NVDA) Stock: Climbs After Launching Powerful Jetson Orin Nano 2
TLDR Nvidia shares rise 1.88% as Jetson Orin Nano 2 boosts edge computing power. Jetson Orin Nano 2 doubles inference performance...
SuperX AI Technology (SUPX) Stock: Expands in Japan With $38.8 Million Nvidia B3...
TLDR SuperX secures a $38.8 million Nvidia B300 server order from Japan’s Woodman SUPX expands in Japan with a $38.8 million Nvidi...
Market Movers: Nvidia (NVDA) Earnings Loom as Dick’s Sporting Goods (DKS) Plunge...
Dick's Sporting Goods drops 27%, Nvidia earnings could move markets $280B, AMD gains on upgrade, and Alibaba insiders buy shares w...
Moderna (MRNA) Stock Soars 14% on Personalized Cancer Vaccine Success: Is It Tim...
Moderna (MRNA) stock jumps 14% as its personalized mRNA cancer vaccine meets Phase 3 trial goals. Analysts boost price targets, bu...
SpaceX (SPCX) Stock Gains Momentum Following JPMorgan’s $240 Price Target Reaffi...
SpaceX (SPCX) stock climbed 1.6% Tuesday as JPMorgan maintained its $240 target, highlighting Grok AI progress and the strategic C...